SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-206196
Filing Date
2024-08-23
Accepted
2024-08-23 16:20:27
Documents
2
Group Members
AMGEN SINGAPORE MANUFACTURING PTE. LTD.AMGEN TECHNOLOGY, LTDONYX PHARMACEUTICALS, INC.SAGA INVESTMENTS COOPERATIEF U.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d856951dsc13ga.htm SC 13G/A 88790
2 EX-99.1 d856951dex991.htm EX-99.1 7547
  Complete submission text file 0001193125-24-206196.txt   98323
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93833 | Film No.: 241236587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)